The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab

Andrea Harrer; M Frommrich; Tobias Moser; S Afazel; Elisabeth Haschke-Becher; Peter Wipfler; Johann Sellner

The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab

Andrea Harrer, M Frommrich, Tobias Moser, S Afazel, Elisabeth Haschke-Becher, Peter Wipfler, Johann Sellner

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	337-338
Journal	MULTIPLE SCLEROSIS
Volume	23
Publication status	Published - 2017
Event	7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) - Paris, FRANCE Duration: 25 Oct 2017 → 28 Oct 2017

Cite this

Harrer, A., Frommrich, M., Moser, T., Afazel, S., Haschke-Becher, E., Wipfler, P., & Sellner, J. (2017). The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab. MULTIPLE SCLEROSIS , 23, 337-338.

Harrer, Andrea ; Frommrich, M ; Moser, Tobias et al. / The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab. In: MULTIPLE SCLEROSIS 2017 ; Vol. 23. pp. 337-338.

@article{0a96f6ff0ed44819a50189b8ceab36cf,

title = "The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab",

author = "Andrea Harrer and M Frommrich and Tobias Moser and S Afazel and Elisabeth Haschke-Becher and Peter Wipfler and Johann Sellner",

year = "2017",

language = "English",

volume = "23",

pages = "337--338",

journal = "MULTIPLE SCLEROSIS ",

issn = "1352-4585",

note = "7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) ; Conference date: 25-10-2017 Through 28-10-2017",

}

Harrer, A, Frommrich, M, Moser, T, Afazel, S, Haschke-Becher, E, Wipfler, P & Sellner, J 2017, 'The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab', MULTIPLE SCLEROSIS , vol. 23, pp. 337-338.

The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab. / Harrer, Andrea; Frommrich, M; Moser, Tobias et al.
In: MULTIPLE SCLEROSIS , Vol. 23, 2017, p. 337-338.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab

AU - Harrer, Andrea

AU - Frommrich, M

AU - Moser, Tobias

AU - Afazel, S

AU - Haschke-Becher, Elisabeth

AU - Wipfler, Peter

AU - Sellner, Johann

PY - 2017

Y1 - 2017

M3 - Abstract (Journal)

SN - 1352-4585

VL - 23

SP - 337

EP - 338

JO - MULTIPLE SCLEROSIS

JF - MULTIPLE SCLEROSIS

T2 - 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)

Y2 - 25 October 2017 through 28 October 2017

ER -

Harrer A, Frommrich M, Moser T, Afazel S, Haschke-Becher E, Wipfler P et al. The immune receptor expression pattern in peripheral-blood associated with JCV seropositivity in patients with multiple sclerosis is not affected by natalizumab. MULTIPLE SCLEROSIS . 2017;23:337-338.